InvestSMART

Sigma Healthcare Limited (ASX: SIG) - ETF Exposure

Current share price for SIG : $2.730 0.01 (0.37%)+

Sigma Healthcare Limited (SIG) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is an Australian retail pharmacy franchisor and full line pharmaceutical wholesale and distributor to community pharmacies. From modest beginnings in Melbourne in FY1912, the company has grown into a vibrant, nationwide network servicing community pharmacy.

SIG General Information +

ASX Code SIG
Website http://sigmahealthcare.com.au
Industry/Sector Health Care Distributors
Market Cap ($M) 31,514
SIG Share Price $2.730
Day High $2.760
Day Low $2.710
Last Close $2.720
SIG Share Price Movement $0.01 ( 0.37% )
Prices as at 16:40, 30 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to SIG

As one of Australia's largest companies by market capitalisation, SIG is held across 35 ETFs spanning strategies that include health care distributors exposure . Its weighting in those funds means performance can have an outsized influence - when SIG moves, funds like XX20, ALFA, AASF, GRNV and TCAP that hold it can move with it.

For more concentrated exposure, ETFs such as XX20 (First Sentier EX-20 Australian Share Active ETF) allocate about 4.1% to SIG , while the average exposure across all 35 ETFs that hold it is around 0.9% .

Top ETF holdings

Last updated: ETF data and holdings as at 31 October 2026

Own SIG directly or through an ETF?

How does holding Sigma Healthcare Limited (SIG) shares directly compare to ETFs that include it?

SIG Direct
XX20
ASX
ALFA
ASX
AASF
ASX
GRNV
ASX
TCAP
ASX
Holdings 1 company 29 holdings 105 holdings 37 holdings 84 holdings 105 holdings
SIG Weight 100% 4.1% 3.1% 3% 1.9% 1.7%
Diversification Single Stock Broad Broad Broad Broad Broad
Annual Cost Brokerage only 0.75% p.a. 0.39% p.a. 0.78% p.a. 0.35% p.a. 0.97% p.a.
Approx. Yield 1.5% 1.53% 0.88% 6.59% 3.54% 2.7%
Star Ratings - star star starstar starstarstarstar starstar

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not SIG's direct yield. Annual cost uses each ETF's MER.

SIG Exposure on $10,000 investment

How a $10,000 investment in Sigma Healthcare Limited (SIG) one week ago compares with ETFs that hold it.

Security Investment type Current price 7-day price movement Dollar change Value today
Sigma Healthcare Limited (SIG) Direct share $2.730 -0.36% -$36 $9,964
First Sentier EX-20 Australian Share Active ETF (XX20) Equity - Australia Strategy $1.260 2.86% +$286 $10,286
Vaneck Australian Long Short Complex ETF (ALFA) Equity - Australia Strategy $22.700 0.40% +$40 $10,040
Airlie Australian Share Fund (Managed Fund) (AASF) Equity - Australia Strategy $3.870 2.11% +$211 $10,211
VanEck MSCI Australian Sustainable Equity ETF (GRNV) Equity - Australia Strategy $32.530 1.28% +$128 $10,128
Ten Cap Alpha Plus Complex ETF (TCAP) Equity - Australia Strategy $9.640 0.31% +$31 $10,031

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Sigma Healthcare Limited (SIG) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
HFResult 2¢ 100% 3 Sep 2026 22 Sep 2026 - - -
Result 2¢ 100% 4 Mar 2026 20 Mar 2026 - - -
HFResult 1.3¢ 100% 2 Sep 2025 18 Sep 2025 - - -

See all dividends from Sigma Healthcare Limited (SIG) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Sigma Healthcare Limited (SIG) price-sensitive announcements

SIG - AGM Trading Update - 21 October 2026
Sigma Healthcare Limited’s AGM trading update dated 21 October 2026 reported continued str
Sigma Healthcare Limited (SIG)
21 Oct 2026 | 8:33 AM
SIG - AGM Presentation to Shareholders
Sigma Healthcare Limited’s 2026 Annual General Meeting presentation outlines the first ful
Sigma Healthcare Limited (SIG)
21 Oct 2026 | 8:32 AM
SIG - AGM Chairman & CEO Address to Shareholders
Sigma Healthcare Limited’s AGM Chairman and CEO address outlines FY26 as a defining first
Sigma Healthcare Limited (SIG)
21 Oct 2026 | 8:31 AM
SIG - Sigma Full Year Results Presentation
Sigma Healthcare Limited’s FY26 Full Year Results Presentation reports strong post-merger
Sigma Healthcare Limited (SIG)
27 Aug 2026 | 8:56 AM

Sigma Healthcare Limited (SIG) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Sigma Healthcare Limited (SIG)
ORDINARY FULLY PAID
Health Care $31,514 Notification of cessation of securities - SIG 23 Oct 2026 3:34PM $2.740 $2.730 fallen by 0.36%
Sigma Healthcare Limited (SIG)
ORDINARY FULLY PAID
Health Care $31,514 Sigma AGM Results of Meeting 21 Oct 2026 4:03PM $2.750 $2.730 fallen by 0.73%
Sigma Healthcare Limited (SIG)
ORDINARY FULLY PAID
Health Care $31,514 AGM Trading Update - 21 October 2026 21 Oct 2026 8:33AM $2.830 $2.730 fallen by 3.53%
Sigma Healthcare Limited (SIG)
ORDINARY FULLY PAID
Health Care $31,514 AGM Presentation to Shareholders 21 Oct 2026 8:32AM $2.830 $2.730 fallen by 3.53%
Sigma Healthcare Limited (SIG)
ORDINARY FULLY PAID
Health Care $31,514 AGM Chairman & CEO Address to Shareholders 21 Oct 2026 8:31AM $2.830 $2.730 fallen by 3.53%
Sigma Healthcare Limited (SIG)
ORDINARY FULLY PAID
Health Care $31,514 Sustainability Report 2026 9 Oct 2026 4:50PM $2.690 $2.730 risen by 1.49%

SIG Financial Summary

Year to Jan NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $295.73 $2.56 806.60% 110.55 1.41 0.50% 100.0%
2025F $32.62 $0.28 -38.50% 1,010.71 0.16 0.06% 100.0%
2024A $4.88 $0.46 -67.40% 159.03 1.00 1.37% 100.0%

SIG Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
EBOS Group Limited (EBO) $3,364M -0.0935 -0.0385 0.1393 14.3239 14.8968 13.0749 6.13% 4.71% 5.34%
Sigma Healthcare Limited (SIG) $31,399M 0.1384 0.1477 0.1408 41.8462 36.4611 31.9624 1.47% 1.65% 1.86%

SIG Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 1.21 40.00 6.29 2.78
Market 0.65 15.30 1.51 1.24
Sector 0.72 21.90 1.74 2.48

SIG Directors

Name Position Start Date
Mr Vikesh Ramsunder Chief Executive Officer, Managing Director 17 Feb 2022
Ms Danielle Di Pilla Executive Director 12 Feb 2025
Mr Mario Verrocchi Executive Director 12 Feb 2025
Mr Damien Gance Executive Director 12 Feb 2025
Dr Christopher Graham Roberts Non-Executive Director 6 Oct 2023
Mr Neville Mitchell Non-Executive Director 2 Feb 2023
Ms Annette May Carey Non-Executive Director 1 Apr 2023
Mr Jack Gance Non-Executive Director 12 Feb 2025
Mr Michael Sammells Non-Executive Director, Non-Executive Chairman 1 Feb 2020

Sigma Healthcare Limited (SIG) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
18 Sep 2026 VERROCCHI, Mario Buy Indirect Shares 2,000,000 $2.546 $5,092,146.160
14 Sep 2026 MITCHELL, Neville Buy Direct Shares 20,000 $2.655 $53,100.000
10 Nov 2025 CAREY, Annette Buy Indirect Shares 10,000 $3.124 $31,237.440

See all changes in directors' interest & trades for Sigma Healthcare Limited (SIG) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

SIG Management

Name Position
Kara McGowan General Counsel, Chief Legal Officer,Company Secretary
Richard Murray CFO
Gary Woodford Other Executive Officer

SIG Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Sigma Healthcare Limited (SIG). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
2,555,284,920 (22.13%) Mario Verrocchi
1,446,864,015 (12.53%) Sam Gance
1,423,948,843 (12.34%) Jack Gance

SIG Calendar of Events

Date Event
26 August 2027 Report (Annual)
26 August 2027 Report (Prelim)
25 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.